Cargando…

DNA Methylation Associates With Clinical Courses of Atypical Meningiomas: A Matched Case–Control Study

BACKGROUND: Accounting for 15–20% of all meningiomas, WHO grade II meningiomas represent an intermediate group regarding risk of tumor recurrence. However, even within this subgroup varying clinical courses are observed with potential occurrence of multiple recurrences. Recently, DNA methylation pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Millesi, Matthias, Ryba, Alice Senta, Hainfellner, Johannes A., Roetzer, Thomas, Berghoff, Anna Sophie, Preusser, Matthias, Heller, Gerwin, Tomasich, Erwin, Sahm, Felix, Roessler, Karl, Wolfsberger, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959647/ https://www.ncbi.nlm.nih.gov/pubmed/35356207 http://dx.doi.org/10.3389/fonc.2022.811729

Ejemplares similares

Prognostic impact of genetic alterations and methylation classes in meningioma
por: Berghoff, Anna S., et al.
Publicado: (2022)

Emerging systemic treatment options in meningioma
por: Mair, Maximilian J., et al.
Publicado: (2022)

Challenging the osseous component of sphenoorbital meningiomas
por: Maschke, Svenja, et al.
Publicado: (2019)

Noninvasive Differentiation of Meningiomas and Dural Metastases Using Intratumoral Vascularity Obtained by Arterial Spin Labeling
por: Furtner, Julia, et al.
Publicado: (2019)

DNA methylation profiles differ in responders versus non-responders to anti-PD-1 immune checkpoint inhibitors in patients with advanced and metastatic head and neck squamous cell carcinoma
por: Starzer, Angelika Martina, et al.
Publicado: (2022)

High Diagnostic Accuracy of Visible 5‐ALA Fluorescence in Meningioma Surgery According to Histopathological Analysis of Tumor Bulk and Peritumoral Tissue
por: Wadiura, Lisa I., et al.
Publicado: (2020)

Clinical Neuropathology Practice Guide 3-2013: levels of evidence and clinical utility of prognostic and predictive candidate brain tumor biomarkers
por: Berghoff, Anna S., et al.
Publicado: (2013)

EVI1 Promotes the Proliferation and Invasive Properties of Human Head and Neck Squamous Cell Carcinoma Cells
por: Grandits, Alexander Michael, et al.
Publicado: (2022)

Tumor DNA methylation profiles correlate with response to anti-PD-1 immune checkpoint inhibitor monotherapy in sarcoma patients
por: Starzer, Angelika M, et al.
Publicado: (2021)

Clinical Neuropathology practice guide 5-2015: MGMT methylation pyrosequencing in glioblastoma: unresolved issues and open questions
por: Bienkowski, Michal, et al.
Publicado: (2015)

Prognostic Value of 5-ALA Fluorescence, Tumor Cell Infiltration and Angiogenesis in the Peritumoral Brain Tissue of Brain Metastases
por: Mercea, Petra A., et al.
Publicado: (2021)

Clinical characteristics and prognostic factors of adult patients with pilocytic astrocytoma
por: Mair, Maximilian J., et al.
Publicado: (2020)

Tumor mutational burden and immune infiltrates in renal cell carcinoma and matched brain metastases
por: Steindl, A., et al.
Publicado: (2021)

LS2 METASTATIC BRAIN TUMORS / MENINGIOMAS: CURRENT CONCEPTS AND THERAPEUTIC PERSPECTIVES
por: Preusser, Matthias
Publicado: (2019)

5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)—Experience at Two Specialized Centers
por: Hosmann, Arthur, et al.
Publicado: (2021)

Reply to Stummer, W.; Thomas, C. Comment on “Hosmann et al. 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)—Experience at Two Specialized Centers. Cancers 2021, 13, 2540”
por: Hosmann, Arthur, et al.
Publicado: (2021)

Clinical neuropathology practice guide 06-2012: MGMT testing in elderly glioblastoma patients – yes, but how?
por: Berghoff, Anna S., et al.
Publicado: (2012)

Anti-angiogenic therapies in brain metastases
por: Berghoff, Anna S., et al.
Publicado: (2018)

New developments in brain metastases
por: Berghoff, Anna S., et al.
Publicado: (2018)

Targeted Therapies for Melanoma Brain Metastases
por: Berghoff, Anna S., et al.
Publicado: (2017)

Rhabdoid meningioma in the petroclival region: An atypical meningioma in an atypical site
por: Kawsar, K. A., et al.
Publicado: (2015)

The Prognostic Value of Methylation Signatures and NF2 Mutations in Atypical Meningiomas
por: Meta, Rahmina, et al.
Publicado: (2021)

5-Aminolevulinic Acid Induced Fluorescence Is a Powerful Intraoperative Marker for Precise Histopathological Grading of Gliomas with Non-Significant Contrast-Enhancement
por: Widhalm, Georg, et al.
Publicado: (2013)

Local image variance of 7 Tesla SWI is a new technique for preoperative characterization of diffusely infiltrating gliomas: correlation with tumour grade and IDH1 mutational status
por: Grabner, Günther, et al.
Publicado: (2016)

MALAT1 Fusions and Basal Cells Contribute to Primary Resistance against Androgen Receptor Inhibition in TRAMP Mice
por: Marhold, Maximilian, et al.
Publicado: (2022)

Systemic inflammation scores correlate with survival prognosis in patients with newly diagnosed brain metastases
por: Starzer, Angelika M., et al.
Publicado: (2021)

MGMT assessment in pituitary adenomas: comparison of different immunohistochemistry fixation chemicals
por: Micko, Alexander S. G., et al.
Publicado: (2018)

New Approaches with Precision Medicine in Adult Brain Tumors
por: Leibetseder, Annette, et al.
Publicado: (2022)

Immune escape mechanisms and therapeutic approaches in cancer: the cancer-immunity cycle
por: Starzer, Angelika M., et al.
Publicado: (2022)

Atypical Meningioma of the Sinonasal Tract
por: Fechtner, Linnea C, et al.
Publicado: (2021)

Predictors of Survival in Atypical Meningiomas
por: Da Broi, Michele, et al.
Publicado: (2021)

Clinical Neuropathology mini-review 6-2015: PD-L1: emerging biomarker in glioblastoma?
por: Preusser, Matthias, et al.
Publicado: (2015)

CECOG educational illustrations: the blood–brain barrier and its relevance for targeted cancer therapies and immuno-oncology
por: Preusser, Matthias, et al.
Publicado: (2017)

Clinical Neuropathology image 6-2018: Metastasis of breast carcinoma to meningioma
por: Klotz, Sigrid, et al.
Publicado: (2018)

CDKN2A/B homozygous deletion is associated with early recurrence in meningiomas
por: Sievers, Philipp, et al.
Publicado: (2020)

Descriptive statistical analysis of a real life cohort of 2419 patients with brain metastases of solid cancers
por: Berghoff, Anna S, et al.
Publicado: (2016)

Atypical meningioma and acute subdural hemorrhage
por: Munivenkatappa, Ashok, et al.
Publicado: (2014)

Atypical Trigeminal Neuralgia Secondary to Meningioma
por: Niwant, Premeshwar, et al.
Publicado: (2015)

Transformation of a meningioma with atypical imaging
por: Kumar, Ashish, et al.
Publicado: (2016)

Atypical Growth Pattern of an Intraparenchymal Meningioma
por: Zeng, Zhen, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_molleet08qhpeohnhn6oreobu1